Sanofi Invests $1.08 Billion in French Biomanufacturing, Boosts EU Health Sovereignty

May 13, 2024, 06:45 AM

Sanofi announced plans to invest over 1 billion euros ($1.08 billion) to enhance its drug and vaccine production capabilities across three of its sites in France. This investment aims to expand biomanufacturing capacities and is part of a broader initiative to promote health sovereignty within the European Union.